Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators
The ability of integrins to activate and integrate intracellular communication illustrates the potential of these receptors to serve as functional distribution hubs in a bi-directional signal transfer outside-in and inside-out of the cells. Tight regulation of the integrin signaling is paramount for...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2017-07-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/9/7/78 |
| _version_ | 1797713437161160704 |
|---|---|
| author | Alessandra Tolomelli Paola Galletti Monica Baiula Daria Giacomini |
| author_facet | Alessandra Tolomelli Paola Galletti Monica Baiula Daria Giacomini |
| author_sort | Alessandra Tolomelli |
| collection | DOAJ |
| description | The ability of integrins to activate and integrate intracellular communication illustrates the potential of these receptors to serve as functional distribution hubs in a bi-directional signal transfer outside-in and inside-out of the cells. Tight regulation of the integrin signaling is paramount for normal physiological functions such as migration, proliferation, and differentiation, and misregulated integrin activity could be associated with several pathological conditions. Because of the important roles of integrins and their ligands in biological development, immune responses, leukocyte traffic, haemostasis, and cancer, their potential as therapeutic tools is now widely recognized. Nowadays extensive efforts have been made to discover and develop small molecule ligands as integrin antagonists, whereas less attention has been payed to agonists. In recent years, it has been recognized that integrin agonists could open up novel opportunities for therapeutics, which gain benefits to increase rather than decrease integrin-dependent adhesion and transductional events. For instance, a significant factor in chemo-resistance in melanoma is a loss of integrin-mediated adhesion; in this case, stimulation of integrin signaling by agonists significantly improved the response to chemotherapy. In this review, we overview results about small molecules which revealed an activating action on some integrins, especially those involved in cancer, and examine from a medicinal chemistry point of view, their structure and behavior. |
| first_indexed | 2024-03-12T07:36:34Z |
| format | Article |
| id | doaj.art-aa241912354b426cab55994a594003ee |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-12T07:36:34Z |
| publishDate | 2017-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-aa241912354b426cab55994a594003ee2023-09-02T21:31:30ZengMDPI AGCancers2072-66942017-07-01977810.3390/cancers9070078cancers9070078Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin ActivatorsAlessandra Tolomelli0Paola Galletti1Monica Baiula2Daria Giacomini3Department of Chemistry “G. Ciamician”, University of Bologna, Via Selmi 2, 40126 Bologna, ItalyDepartment of Chemistry “G. Ciamician”, University of Bologna, Via Selmi 2, 40126 Bologna, ItalyDepartment of Pharmacy and Biotechnology, University of Bologna, Via Irnerio 48, 40126 Bologna, ItalyDepartment of Chemistry “G. Ciamician”, University of Bologna, Via Selmi 2, 40126 Bologna, ItalyThe ability of integrins to activate and integrate intracellular communication illustrates the potential of these receptors to serve as functional distribution hubs in a bi-directional signal transfer outside-in and inside-out of the cells. Tight regulation of the integrin signaling is paramount for normal physiological functions such as migration, proliferation, and differentiation, and misregulated integrin activity could be associated with several pathological conditions. Because of the important roles of integrins and their ligands in biological development, immune responses, leukocyte traffic, haemostasis, and cancer, their potential as therapeutic tools is now widely recognized. Nowadays extensive efforts have been made to discover and develop small molecule ligands as integrin antagonists, whereas less attention has been payed to agonists. In recent years, it has been recognized that integrin agonists could open up novel opportunities for therapeutics, which gain benefits to increase rather than decrease integrin-dependent adhesion and transductional events. For instance, a significant factor in chemo-resistance in melanoma is a loss of integrin-mediated adhesion; in this case, stimulation of integrin signaling by agonists significantly improved the response to chemotherapy. In this review, we overview results about small molecules which revealed an activating action on some integrins, especially those involved in cancer, and examine from a medicinal chemistry point of view, their structure and behavior.https://www.mdpi.com/2072-6694/9/7/78integrinsagonistsligandssignalinglactamsRGD mimeticsactivation |
| spellingShingle | Alessandra Tolomelli Paola Galletti Monica Baiula Daria Giacomini Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators Cancers integrins agonists ligands signaling lactams RGD mimetics activation |
| title | Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators |
| title_full | Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators |
| title_fullStr | Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators |
| title_full_unstemmed | Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators |
| title_short | Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators |
| title_sort | can integrin agonists have cards to play against cancer a literature survey of small molecules integrin activators |
| topic | integrins agonists ligands signaling lactams RGD mimetics activation |
| url | https://www.mdpi.com/2072-6694/9/7/78 |
| work_keys_str_mv | AT alessandratolomelli canintegrinagonistshavecardstoplayagainstcanceraliteraturesurveyofsmallmoleculesintegrinactivators AT paolagalletti canintegrinagonistshavecardstoplayagainstcanceraliteraturesurveyofsmallmoleculesintegrinactivators AT monicabaiula canintegrinagonistshavecardstoplayagainstcanceraliteraturesurveyofsmallmoleculesintegrinactivators AT dariagiacomini canintegrinagonistshavecardstoplayagainstcanceraliteraturesurveyofsmallmoleculesintegrinactivators |